liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Apoptosis and cancer: mutations within caspase genes
University of Manitoba, Winnipeg, Canada.
Zahedan University of Medical Sciences, Iran .
MICB, CancerCare Manitoba, Winnipeg, Canada.
St Boniface General Hospital Research Centre and University of Manitoba, Winnipeg, Canada.
Visa övriga samt affilieringar
2009 (Engelska)Ingår i: Journal of Medical Genetics, ISSN 0022-2593, E-ISSN 1468-6244, Vol. 46, nr 8, s. 497-510Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

The inactivation of programmed cell death has profound effects not only on the development but also on the overall integrity of multicellular organisms. Beside developmental abnormalities, it may lead to tumorigenesis, autoimmunity, and other serious health problems. Deregulated apoptosis may also be the leading cause of cancer therapy chemoresistance. Caspase family of cysteinyl-proteases plays the key role in the initiation and execution of programmed cell death. This review gives an overview of the role of caspases, their natural modulators like IAPs, FLIPs, and Smac/Diablo in apoptosis and upon inactivation, and also in cancer development. Besides describing the basic mechanisms governing programmed cell death, a large part of this review is dedicated to previous studies that were focused on screening tumours for mutations within caspase genes as well as their regulators. The last part of this review discusses several emerging treatments that involve modulation of caspases and their regulators. Thus, we also highlight caspase cascade modulating experimental anticancer drugs like cFLIP-antagonist CDDO-Me; cIAP1 antagonists OSU-03012 and ME-BS; and XIAP small molecule antagonists 1396-11, 1396-12, 1396-28, triptolide, AEG35156, survivin/Hsp90 antagonist shephedrin, and some of the direct activators of procaspase-3.

Ort, förlag, år, upplaga, sidor
B M J Group , 2009. Vol. 46, nr 8, s. 497-510
Nationell ämneskategori
Medicin och hälsovetenskap
Identifikatorer
URN: urn:nbn:se:liu:diva-85190DOI: 10.1136/jmg.2009.066944ISI: 000268541500001PubMedID: 19505876OAI: oai:DiVA.org:liu-85190DiVA, id: diva2:566576
Tillgänglig från: 2012-11-08 Skapad: 2012-11-08 Senast uppdaterad: 2017-12-07

Open Access i DiVA

fulltext(346 kB)2545 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 346 kBChecksumma SHA-512
98bc2ef0706674333e7abb00c99867e8f4d44046d28f85b1c83c096ff204697b76d20f17455600c32a61224816407281cd9e153f61e6e9eba48e57d1115c5d2e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Wiechec, EmiliaLos, Marek

Sök vidare i DiVA

Av författaren/redaktören
Wiechec, EmiliaLos, Marek
I samma tidskrift
Journal of Medical Genetics
Medicin och hälsovetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 2545 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 397 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf